	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S17-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S17-BMJ_2010_Apr_29_340_c1640	['this latitudinal gradient SEEMS environmentally RELATED BECAUSE the risk ASSOCIATED with latitude alters if People move after Birth.45a strong environmental CANDIDATE is the level of ambient regional ultraviolet radiation, acting EITHER directly OR through the generation of Vitamin D.6higher exposure to ultraviolet radiation,7higher Vitamin D intake,8and also higher Serum Vitamin D concentrations9seem to be ASSOCIATED with a reduced risk of onset of multiple sclerosis.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230), ('SUPERFICIAL_RELATIONSHIP', 411)]	7	[('NCBITaxon_10088', 'Mus <genus>', 108, 'people'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('UBERON_0001977', 'blood serum', 369, 'serum'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D')]
S18-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
S94-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S94-BMJ_2010_Apr_29_340_c1640	['in this setting, there is STRONG a priori EVIDENCE that sun exposure or Vitamin D, or both, is LIKELY to be the central exposure6and LITTLE a priori evidence for any other strong DETERMINANT of multiple sclerosis LIKELY to be LINKED to maternal ambient Ultraviolet radiation exposure during the first Trimester.']	[('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 42), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 179), ('PROBABLE_UNDERSTANDING', 213), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 253, 'ultraviolet'), ('GO_0009294', 'DNA mediated transformation', 301, 'trimester')]
S96-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S96-BMJ_2010_Apr_29_340_c1640	['by the time of Delivery, maternal and infant Cord Serum 25-Hydroxyvitamin d3concentrations are highly CORRELATED.37UNFORTUNATELY, much REMAINS UNKNOWN, leading to large international variations in maternal Vitamin D monitoring and supplementation during Pregnancy.353839\na maternal EFFECT operating Antenatally would also be CONSISTENT with the stronger maternal than paternal “parent of origin” EFFECT in familial multiple sclerosis.1340it HAS BEEN PREVIOUSLY PROPOSED14THAT maternal Vitamin D deficiency, a PROBLEM for SOME dark skinned women migrating to regions with low ambient ultraviolet radiation, such as the uk, MIGHT EXPLAIN the increase in incidence of disease SEEN among second generation migrants in such locations.41our FINDINGS are CONSISTENT with this EXPLANATION.']	[('SUPERFICIAL_RELATIONSHIP', 102), ('ANOMALY_CURIOUS_FINDING', 113), ('ANOMALY_CURIOUS_FINDING', 113), ('FULL_UNKNOWN', 135), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 325), ('SUPERFICIAL_RELATIONSHIP', 396), ('INCOMPLETE_EVIDENCE', 441), ('INCOMPLETE_EVIDENCE', 450), ('INCOMPLETE_EVIDENCE', 461), ('IMPORTANT_CONSIDERATION', 509), ('INCOMPLETE_EVIDENCE', 521), ('INCOMPLETE_EVIDENCE', 622), ('PROBABLE_UNDERSTANDING', 628), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 735), ('INCOMPLETE_EVIDENCE', 748), ('PROBABLE_UNDERSTANDING', 769)]	18	[('GO_0007567', 'parturition', 15, 'delivery'), ('UBERON_0002240', 'spinal cord', 45, 'cord'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 56, '25-hydroxyvitamin'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy'), ('GO_0007288', 'sperm axoneme assembly', 299, 'antenatally'), ('CHEBI_27300', 'vitamin D', 485, 'vitamin D')]
S103-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
S72-PMC2290997	PMC2290997	4/2008	S72-PMC2290997	['for example, there is substantial THOUGH not DEFINITIVE EVIDENCE that high levels of Vitamin D EITHER from diet or from uvr exposure MAY decrease the risk of developing multiple sclerosis (ms).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 133)]	5	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S86-PMC2290997	PMC2290997	4/2008	S86-PMC2290997	['“moreover, there is an inflammatory component to atherosclerosis, and Vascular Smooth Muscle Cells have a Vitamin D receptor and relax in the presence of 1,25(Oh)D, SUGGESTING a multitude of mechanisms by which Vitamin D MAY BE cardioprotective.”\nTO DETERMINE the POTENTIAL LINK betwen sun exposure and the PROTECTIVE effect in preventing hypertension, rolfdieter krause of the free university of berlin department of natural medicine and colleagues exposed a group of hypertensive Adults to a Tanning Bed that emitted full-spectrum uvr similar to summer sunlight.']	[('INCOMPLETE_EVIDENCE', 165), ('INCOMPLETE_EVIDENCE', 221), ('QUESTION_ANSWERED_BY_THIS_WORK', 247), ('INCOMPLETE_EVIDENCE', 264), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 307)]	6	[('CL_0000359', 'vascular associated smooth muscle cell', 70, 'vascular smooth muscle cells'), ('UBERON_0004237', 'blood vessel smooth muscle', 70, 'vascular smooth muscle'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 158, '(OH)D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('UBERON_0007023', 'adult organism', 482, 'adults'), ('UBERON_0002544', 'digit', 494, 'tanning'), ('UBERON_0002531', 'paired fin bud', 502, 'bed')]
S185-PMC2646054	PMC2646054	3/2009	S185-PMC2646054	['experiments in hypercholesterolemic Rabbits HAVE SHOWN that administration of the antioxidant Vitamin E during Pregnancy resulted in reduced atherosclerotic lesions in the offspring (16,17), INDICATING that maternal oxidative stress LIKELY plays a ROLE in maternal programming for atherosclerosis.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 191), ('PROBABLE_UNDERSTANDING', 233), ('SUPERFICIAL_RELATIONSHIP', 248)]	4	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rabbits'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin E'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
S18-PMC2798111	PMC2798111	12/2010	S18-PMC2798111	"[""furthermore, Vitamin D deficiency HAS BEEN ASSOCIATED with a NUMBER OF disease states including but certainly not limited to rheumatoid arthritis [10], multiple sclerosis [11–14], type i and ii diabetes [15–19], crohn's disease [20], Cardiovascular disease [21,22], and a NUMBER of cancers [23,24].""]"	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 272)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 234, 'cardiovascular')]
S34-PMC2821652	PMC2821652	2/2010	S34-PMC2821652	['WHILE rickets HAS BEEN traditionally THOUGHT TO be the main sequelae of Vitamin D deficiency, numerous OTHER long-latency disease states (such as multiple sclerosis [23–25], rheumatoid arthritis [26–29], type 1 and 2 diabetes [30–34], Cardiovascular disease [35,36], various cancers [37–43], and systemic lupus erythematosus [44], to name BUT a few) as well as acute infections such as Upper Respiratory illnesses [45] and tuberculosis [46,47] are now LINKED with Vitamin D deficiency that are EXPLAINED by alterations in Immune function [47–49].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 339), ('SUPERFICIAL_RELATIONSHIP', 452), ('PROBABLE_UNDERSTANDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 235, 'cardiovascular'), ('UBERON_0001154', 'vermiform appendix', 386, 'upper respiratory'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0002405', 'immune system', 522, 'immune')]
S128-PMC2873552	PMC2873552	4/2010	S128-PMC2873552	"[""caption (table-wrap): table 2\n\nfunctions and diseases related to both ceu and yri Signaturesceuyri diabetes 1.70e-172.70e-20 Coronary Artery disease 3.78e-173.12e-13 Genetic disorder 1.09e-144.53e-14 Cardiovascular disease 1.34e-144.78e-11 non-Insulin-dependent diabetes mellitus 1.03e-128.66e-15 Endocrine System disorder 1.91e-121.25e-18 hypertension 2.13e-122.83e-11 Neurological disorder 2.49e-123.27e-12 crohn's disease 7.59e-127.25e-09 bipolar affective disease 3.50e-115.24e-09 Metabolic disorder 5.66e-119.83e-16 inflammatory disorder 2.56e-091.08e-08 Digestive System disorder 2.66e-091.31e-07 Skeletal and muscular disorder 1.49e-081.58e-08 progressive motor neuropathy 2.53e-085.59e-12 Autoimmune disease 7.28e-081.09e-12 immunological disorder 2.46e-073.66e-13 rheumatoid arthritis 3.78e-072.54e-07 shape change of Epithelial Cells 8.86e-07 alzheimer's disease 3.60e-062.27e-07 parkinson's disease 7.24e-065.29e-06 shape change of Dermal Cells 9.33e-06 Insulin-dependent diabetes mellitus 3.76e-15 neuropathy 5.38e-12 amyotrophic lateral sclerosis 1.36e-09 arthritis 1.44e-07\n\nVitamin D HYPOTHESIS\nan INTERESTING HYPOTHESIS HAS BEEN PROPOSED by mcgrace [28] claiming that low Prenatal Vitamin D increases the risk of a wide range of diseases such as multiple sclerosis, diabetes, schizophrenia, Prostate cancer, Breast cancer and Colorectal cancer because of its versatile function in normal development.""]"	[('INCOMPLETE_EVIDENCE', 1099), ('ANOMALY_CURIOUS_FINDING', 1113), ('INCOMPLETE_EVIDENCE', 1125), ('INCOMPLETE_EVIDENCE', 1136), ('INCOMPLETE_EVIDENCE', 1145)]	5	[('GO_0036367', 'light adaption', 82, 'signaturesCEUYRI'), ('UBERON_0001621', 'coronary artery', 125, 'Coronary artery'), ('SO_0000704', 'gene', 166, 'Genetic'), ('UBERON_0004535', 'cardiovascular system', 200, 'Cardiovascular'), ('PR_000045358', 'insulin family protein', 244, 'insulin'), ('UBERON_0000949', 'endocrine system', 297, 'Endocrine system'), ('UBERON_0001016', 'nervous system', 370, 'Neurological'), ('GO_0008152', 'metabolic process', 485, 'Metabolic'), ('UBERON_0004854', 'gastrointestinal system mesentery', 560, 'Digestive system'), ('UBERON_0004288', 'skeleton', 603, 'Skeletal'), ('UBERON_0005445', 'segment of pes', 697, 'Autoimmune'), ('CL_0000066', 'epithelial cell', 827, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 827, 'epithelial'), ('CL_0000346', 'hair follicle dermal papilla cell', 943, 'dermal cells'), ('PR_000045358', 'insulin family protein', 965, 'Insulin'), ('CHEBI_28384', 'vitamin K', 1089, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1188, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1197, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 1307, 'prostate'), ('UBERON_0000310', 'breast', 1324, 'breast'), ('UBERON_0012652', 'colorectum', 1342, 'colorectal')]
S156-PMC3004407	PMC3004407	12/2010	S156-PMC3004407	['given RECENT DISCOVERIES that LINK Vitamin D with the innate Immune System [6], it is not UNREASONABLE to predict that deficiencies during fetal development COULD have lasting sequelae on the child, NOT ONLY in terms of bone mineralization, BUT ALSO in terms of Immune Development that becomes the basis for later derangements SEEN with long-latency diseases such as multiple sclerosis, rheumatoid arthritis, diabetes, and certain cancers [59].']	[('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 157), ('ANOMALY_CURIOUS_FINDING', 199), ('ANOMALY_CURIOUS_FINDING', 241), ('INCOMPLETE_EVIDENCE', 327)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007566', 'embryo implantation', 61, 'immune'), ('UBERON_0002405', 'immune system', 61, 'immune system'), ('GO_0001822', 'kidney development', 262, 'immune development'), ('UBERON_0002405', 'immune system', 262, 'immune')]
S0-PMC3075531	PMC3075531	7/2010	S0-PMC3075531	['a comparative study of 25 (Oh) Vitamin D Serum levels in patients with multiple sclerosis and control group in isfahan, iran\n\nabstract\n\nobjectives:\nthere is NO STUDY about CORRELATION between Vitamin D Serum level and multiple sclerosis (ms) in iran.']	[('FULL_UNKNOWN', 157), ('SUPERFICIAL_RELATIONSHIP', 172)]	2	[('CHEBI_30778', 'gallic acid', 23, '25 (OH)'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 41, 'Serum'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('UBERON_0001977', 'blood serum', 202, 'serum')]
S10-PMC3075531	PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
S61-PMC3075531	PMC3075531	7/2010	S61-PMC3075531	['conclusions\nin conclusion, THIS STUDY SHOWED that Serum Vitamin D deficiency MIGHT be a POTENTIAL environmental predisposing FACTOR for developing multiple sclerosis in our region, and NEED to follow FACTORS that cause THIS PROBLEM including dietary, Genetic, and other ones.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 185), ('SUPERFICIAL_RELATIONSHIP', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 219), ('IMPORTANT_CONSIDERATION', 224)]	9	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('SO_0000704', 'gene', 251, 'genetic')]
S65-PMC3075531	PMC3075531	7/2010	S65-PMC3075531	['furthermore, screening of Serum 25-Hydroxyvitamin D concentrations is LIKELY to identify a large proportion of patients who are Vitamin D deficient or insufficient, and who MIGHT BENEFIT from Vitamin D supplementation for PREVENTION of osteoporosis and other complications, especially multiple sclerosis.']	[('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 173), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 222)]	4	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 32, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
S134-PMC3257641	PMC3257641	3/2010	S134-PMC3257641	['OBSERVATIONAL studies provide INDIRECT EVIDENCE that low Vitamin D status during early Life MAY increase the RISK of multiple sclerosis [107,108].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0000104', 'life cycle', 87, 'life')]
S20-PMC3347007	PMC3347007	4/2012	S20-PMC3347007	['OTHER SUGGESTED CONSEQUENCES of Vitamin D deficiency during Pregnancy are increased risks of: schizophrenia, type 1 diabetes, multiple sclerosis, Heart disease, cancer, and small for Gestational age diagnosis [10,11,12,13].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBLEM_COMPLICATION', 16)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('UBERON_0000948', 'heart', 146, 'heart'), ('GO_0007565', 'female pregnancy', 183, 'gestational')]
S78-PMC3347028	PMC3347028	3/2012	S78-PMC3347028	['these in vitro FINDINGS HELP to EXPLAIN the significant ASSOCIATION between Vitamin D deficiency and Autoimmune diseases, such as systemic lupus erythematosus [25], multiple sclerosis [26,27,28,29,30,31,32,33,34,35], rheumatoid arthritis [31,36,37], diabetes—both types 1 [31,38,39,40,41,42] and 2 [43,44,45], and certain cancers, such as Colon [46,47,48,49], Breast [50,51,52,53,54,55], and Prostate [55,56,57,58,59].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 24), ('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 101, 'autoimmune'), ('UBERON_0001155', 'colon', 339, 'colon'), ('UBERON_0000310', 'breast', 360, 'breast'), ('UBERON_0002367', 'prostate gland', 392, 'prostate')]
S155-PMC3347028	PMC3347028	3/2012	S155-PMC3347028	['mcgrath and others continue to investigate WHETHER there are lasting EFFECTS of fetal and early infancy Vitamin D deficiency on later Adult disease processes such as Anatomical changes of the Brain, schizophrenia, multiple sclerosis, certain cancers, Cardiovascular disease, and various other Autoimmune diseases such as diabetes and lupus [106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adult'), ('UBERON_0001062', 'anatomical entity', 166, 'anatomical'), ('UBERON_0000955', 'brain', 192, 'brain'), ('UBERON_0004535', 'cardiovascular system', 251, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 293, 'autoimmune')]
S0-PMC3395583	PMC3395583	7/2012	S0-PMC3395583	['month of Birth, Vitamin D and risk of Immune-mediated disease: a case control study\n\nabstract\n\nbackground\na season of Birth EFFECT in Immune-mediated diseases (id) such as multiple sclerosis and type 1 diabetes HAS BEEN CONSISTENTLY REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 211), ('PROBABLE_UNDERSTANDING', 220), ('INCOMPLETE_EVIDENCE', 233)]	4	[('GO_0007567', 'parturition', 9, 'birth'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002405', 'immune system', 38, 'immune'), ('GO_0007567', 'parturition', 118, 'birth'), ('UBERON_0002405', 'immune system', 134, 'immune')]
S1-PMC3395583	PMC3395583	7/2012	S1-PMC3395583	"[""we AIMED TO INVESTIGATE WHETHER season of Birth INFLUENCES the risk of rheumatoid arthritis, crohn's disease, ulcerative colitis and systemic lupus erythematosus in addition to multiple sclerosis, and TO EXPLORE the CORRELATION between the risk of id and predicted ultraviolet b (uvb) light exposure and Vitamin D status during Gestation.""]"	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('GO_0007567', 'parturition', 42, 'birth'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('GO_0007565', 'female pregnancy', 328, 'gestation')]
S22-PMC3476426	PMC3476426	8/2012	S22-PMC3476426	['RECENTLY, Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders, including multiple sclerosis (ms) and systemic lupus erythematosus (sle) [5-7].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 103, 'autoimmune')]
S17-PMC3501517	PMC3501517	11/2012	S17-PMC3501517	['Autoimmune diseases such as type 1 diabetes[10], multiple sclerosis[11]and asthma[12],[13]HAVE BEEN ASSOCIATED with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 100)]	2	[('UBERON_0005445', 'segment of pes', 0, 'Autoimmune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S23-PMC3504157	PMC3504157	11/2012	S23-PMC3504157	['MANY health providers NOW RECOMMEND nhps including Prenatal Vitamins, iron supplementation, calcium, and Vitamin D for a range of RECOGNIZED indications including deficiency states such as rickets and anemia, as well as illnesses such as multiple sclerosis.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 22), ('FUTURE_WORK', 26), ('PROBABLE_UNDERSTANDING', 130)]	4	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 60, 'vitamins'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
S243-PMC3613945	PMC3613945	2/2013	S243-PMC3613945	['ongoing interventional trials with Vitamin D and ASSOCIATION studies with larger cohorts MAY offer FURTHER OPPORTUNITY to explore an INTERACTIVE ROLE of dbp Snps with Vitamin D in ms.\n\namyotrophic lateral sclerosis\namyotrophic lateral sclerosis (als) is another neuropathy of UNKNOWN etiology that is characterized by the progressive loss of Motor Neurons in the Brain and spinal Cord, leading to debilitating, USUALLY fatal, muscle atrophy180.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 145), ('FULL_UNKNOWN', 276), ('INCOMPLETE_EVIDENCE', 411)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000694', 'SNP', 157, 'SNPs'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CL_0000100', 'motor neuron', 342, 'motor neurons'), ('UBERON_0000955', 'brain', 363, 'brain'), ('UBERON_0002240', 'spinal cord', 380, 'cord')]
S132-PMC3659910	PMC3659910	1/2013	S132-PMC3659910	['while there is INTEREST in the ROLE of Vitamin D in the PREVENTION of multiple sclerosis, following epidemiological STUDIES DEMONSTRATING an ASSOCIATION between Vitamin D supplementation and reduced PREVALENCE of the disease, FUTURE RESEARCH, including randomized controlled trials in Pregnant or nonpregnant Individuals, is AWAITED TO CONFIRM OR REFUTE such BENEFIT.']	[('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 141), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 226), ('FUTURE_WORK', 325), ('FUTURE_WORK', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('IMPORTANT_CONSIDERATION', 359)]	13	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 285, 'pregnant'), ('NCBITaxon_1', 'root', 309, 'individuals')]
S160-PMC3705146	PMC3705146	5/2013	S160-PMC3705146	['furthermore, a RECENT report DEMONSTRATES an equivalently strong season-of-Birth EFFECT in multiple sclerosis with peaks in april and may and in PARALLEL with schizophrenia (torrey et al.,1997; davies et al.,2003), deficits in births of future multiple sclerosis patients during october and november (dobson et al.,2013), a FINDING the authors ATTRIBUTE to VARIATIONS in sunlight during Gestation and to the resulting variations in Vitamin D availability.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 81), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 324), ('SUPERFICIAL_RELATIONSHIP', 344), ('DIFFICULT_TASK', 357)]	7	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007565', 'female pregnancy', 387, 'gestation'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D')]
S36-PMC3760821	PMC3760821	9/2013	S36-PMC3760821	['additionally, there is EMERGING EVIDENCE DEMONSTRATING an ASSOCIATION between foetal and early childhood Vitamin D deficiency and later Adult disease processes, such as multiple sclerosis, cardiovascular disease, schizophrenia, certain cancers and other Autoimmune diseases such as t1dm and lupus[16].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 136, 'adult'), ('UBERON_0001442', 'skeleton of manus', 254, 'autoimmune')]
S68-PMC3991049	PMC3991049	11/2013	S68-PMC3991049	['SEVERAL STUDIES have REPORTED ASSOCIATION between infant size and Vitamin D status.13,14reduced concentration of 25-Hydroxyvitamin D in mothers during late Pregnancy is ASSOCIATED with reduced Whole Body and Lumbar-Spine bone Mineral content in their children at the age of 9 years.15several studies HYPOTHESIZED that low Prenatal and Perinatal Vitamin D concentrations AFFECT the functional characteristics of various Tissues of the body, which leads to greater risk in later Life of multiple sclerosis, cancer, Insulin-dependent diabetes mellitus and schizophrenia.16,17\nthe current RECOMMENDED dose of Vitamin D during Pregnancy DIFFERS in DIFFERENT parts of the world.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 300), ('SUPERFICIAL_RELATIONSHIP', 370), ('FUTURE_WORK', 585), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 632), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643)]	9	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 113, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('UBERON_0000468', 'multicellular organism', 193, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 208, 'lumbar-spine'), ('CHEBI_46662', 'mineral', 226, 'mineral'), ('GO_0007565', 'female pregnancy', 322, 'prenatal'), ('GO_0036268', 'swimming', 335, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 335, 'perinatal'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0000479', 'tissue', 419, 'tissues'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('PR_000045358', 'insulin family protein', 513, 'insulin'), ('CHEBI_27300', 'vitamin D', 605, 'vitamin D'), ('GO_0007565', 'female pregnancy', 622, 'pregnancy')]
S196-PMC4045304	PMC4045304	2/2014	S196-PMC4045304	['CANNALL used one of the inherited components of the Vitamin D system and Vitamin D RELATED disease, atherosclerosis, as a MODEL to illustrate the mechanism of ASSOCIATION between autism and the Vitamin D system.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 159)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
S1560-PMC4113768	PMC4113768	7/2014	S1560-PMC4113768	['conclusions: upon bivariate analysis, we OBSERVED a CORRELATION between Vitamin D and Cmv Antibody titre, SIMILAR in magnitude to a PREVIOUSLY PUBLISHED CORRELATION between Vitamin D and Ebna1 titres (salzer j, nystrom m, hallmans g, stenlund h, wadell g, sundstrom p. epstein-barr virus Antibodies and Vitamin D in prospective multiple sclerosis biobank samples.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 153)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 86, 'CMV'), ('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibody'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('PR_000006877', 'Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial', 187, 'EBNA1'), ('GO_0042571', 'immunoglobulin complex, circulating', 288, 'antibodies'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
S2043-PMC4113768	PMC4113768	7/2014	S2043-PMC4113768	['the RECENT iom 2011 report on dietary reference intakes for Calcium and Vitamin D for north america is apt for the irish population by providing the most COMPREHENSIVE EVIDENCE-BASED REPORT on Vitamin D.\nmethods: since 2007, we have conducted studies of Vitamin D status by measuring Serum 25-Hydroxy Vitamin D (25Ohd) in: preterm infants shortly after Birth ( n = 274) and after 15 weeks ( n = 148); paired term infants and mothers at Birth ( n = 39); children and adolescents from age 1 to 18 years ( n = 252); mothers during Pregnancy and infants at Birth divided according to winter Birth ( n = 30) and summer Birth ( n = 30); Pregnant mothers and ethnicity ( n = 116); patients attending an osteoporosis clinic ( n = 100); patients with cystic fibrosis ( n = 114); patients with multiple sclerosis ( n = 331) compared with healthy relatives ( n = 229) during winter months in 3 different regions in ireland; and patients with psoriasis undergoing phototherapy during the winter months ( n = 29) compared with controls ( n = 29).']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 168), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 183)]	6	"[('CHEBI_31341', 'calcium dihydroxide', 60, 'Calcium'), ('CHEBI_28384', 'vitamin K', 72, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 201, 'D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('UBERON_0001977', 'blood serum', 284, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 290, '25-hydroxy vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 312, '25OHD'), ('GO_0007567', 'parturition', 353, 'birth'), ('GO_0007567', 'parturition', 436, 'birth'), ('GO_0007565', 'female pregnancy', 528, 'pregnancy'), ('GO_0007567', 'parturition', 553, 'birth'), ('GO_0007567', 'parturition', 587, 'birth'), ('GO_0007567', 'parturition', 614, 'birth'), ('GO_0007565', 'female pregnancy', 631, 'pregnant')]"
S2045-PMC4113768	PMC4113768	7/2014	S2045-PMC4113768	['results: prevalence for Vitamin D status (25Ohd nmol/l < 30, 30–50, > 50–125, > 125) was NOTED for the following groups: preterm at 3 weeks (14%, 65%, 21%, 0%); preterm at 15 weeks on 400 iu/day (3%, 11%, 86%, 8%); Pregnant women at term (21%, 34%, 45%, 0%) with Cord Blood at term (59%, 28%, 13%, 0%); children ranging from 1–18 years (22%, 33%, 45%, 0%); osteoporosis on 400–800 iu/day (1%, 8%, 91%, 2%); and cystic fibrosis on 400–1600 iu/d (23%, 28%, 49%, 3%); healthy Adults in winter (21%, 46%, 33%, 0%); and multiple sclerosis in winter (40%, 32%, 28%, 1%).']	[('ANOMALY_CURIOUS_FINDING', 89)]	1	"[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 42, '25OHD'), ('GO_0007565', 'female pregnancy', 215, 'pregnant'), ('UBERON_0002240', 'spinal cord', 263, 'cord'), ('UBERON_0000178', 'blood', 268, 'blood'), ('UBERON_0007023', 'adult organism', 473, 'adults')]"
S2836-PMC4113768	PMC4113768	7/2014	S2836-PMC4113768	['CORRELATIONS between Vitamin D Serum levels, Nailfold microangiopathy and clinical features in systemic sclerosis patients\n\npaolino, s.; pizzorni, c.; smith, v.; decuman, s.; sulli, a.; seriolo, b.; cutolo, m.\nbackground: Vitamin D (25-Hydroxy Vitamin D) [25(Oh)D3] and its active Metabolite [1,25(Oh)D3] are INVOLVED in the Regulation Of both Innate and Adaptive Immunity (cutolo, m., et al.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 309)]	2	[('CHEBI_28384', 'vitamin K', 21, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 21, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 31, 'Serum'), ('UBERON_0009073', 'dorsobronchus', 45, 'Nailfold'), ('CHEBI_28384', 'vitamin K', 222, 'Vitamin D'), ('CHEBI_43141', '3-hydroxypropoxy group', 233, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 256, '25(OH)'), ('CHEBI_29238', 'tritium atom', 262, 'D3'), ('PR_000001177', 'D(2) dopamine receptor', 262, 'D3'), ('CHEBI_39382', 'flufenoxuron', 281, 'metabolite'), ('CHEBI_17996', 'chloride', 294, ','), ('CHEBI_62946', 'ammonium sulfate', 295, '25(OH)D3'), ('GO_0002222', 'stimulatory killer cell immunoglobulin-like receptor signaling pathway', 325, 'regulation of ... innate ... adaptive immunity')]
S231-PMC4161944	PMC4161944	9/2014	S231-PMC4161944	['independent of nutrition or pathogen exposure, seasonality CAN also change diurnal exposure to sunlight and levels of circulating Vitamin D. in the united kingdom, Vitamin D status during Gestation and Birth month HAS BEEN ASSOCIATED with diseases with Immune involvement, including rheumatoid arthritis, irritable Bowel diseases, and multiple sclerosis (174).']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 223)]	3	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'gestation'), ('GO_0007567', 'parturition', 202, 'birth'), ('UBERON_0002405', 'immune system', 253, 'immune'), ('UBERON_0000160', 'intestine', 315, 'bowel')]
S17-PMC4188019	PMC4188019	1/2010	S17-PMC4188019	['25-Oh Vitamin D deficiency is ASSOCIATED with an INCREASED RISK of developing preeclampsia (bodnar et al., 2007; haugen et al., 2009), multiple sclerosis (hayes et al., 1997; pierrot-deseilligny, 2009) and schizophrenia (mcgrath, 1999; mcgrath et al., 2003).']	[('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 49)]	2	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 0, '25-OH'), ('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
S26-PMC4251419	PMC4251419	12/2014	S26-PMC4251419	['lower Vitamin D status HAS BEEN LINKED to increased risk of multiple sclerosis (see case study [14]) and to type 1 diabetes [15], although not all studies SHOW a PROTECTIVE ASSOCIATION [16].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
S68-PMC4251419	PMC4251419	12/2014	S68-PMC4251419	['multiple sclerosis: a case study\none of the earliest INDICATIONS of an ASSOCIATION between Vitamin D and disorders of Human Immune function was the geographical variation in prevalence of multiple sclerosis, as first described in 1922 [36].']	[('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('UBERON_0002405', 'immune system', 124, 'immune')]
S71-PMC4251419	PMC4251419	12/2014	S71-PMC4251419	['YET, DESPITE PLAUSIBLE immunological pathways whereby Vitamin D (through stimulation of tregsand dampening of T Helper Type 1 over-reactivity) COULD diminish the risk of multiple sclerosis or disease activity, Vitamin D supplementation trials HAVE SHOWN immunological [42] and radiological [43], BUT NOT CLINICAL, benefit for People with multiple sclerosis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 243), ('FULL_UNKNOWN', 296), ('ANOMALY_CURIOUS_FINDING', 300)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0002061', 'T-helper 9 cell', 110, 'T helper'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 110, 'T helper type 1'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 326, 'people')]
S79-PMC4251419	PMC4251419	12/2014	S79-PMC4251419	['additionally, WHILE increased sun exposure during childhood was inversely ASSOCIATED with risk of multiple sclerosis, there was no decreased risk associated with intake of Vitamin D supplements during childhood [40].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
S86-PMC4251419	PMC4251419	12/2014	S86-PMC4251419	['ALTHOUGH childhood Vitamin D levels and sun exposure APPEAR TO BE IMPORTANT DETERMINANTS of the risk of disease onset, higher 25(Oh)D levels early in the disease course MAY PREDICT the rate of disease progression in multiple sclerosis [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 53), ('IMPORTANT_CONSIDERATION', 66), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
S66-PMC4329745	PMC4329745	10/2014	S66-PMC4329745	['insufficient Vitamin D MAY increase the RISK of Colon, Prostate, Breast and skin cancer as well as diabetes types i, multiple sclerosis and Arterial diseases.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 40)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0001155', 'colon', 48, 'colon'), ('UBERON_0002367', 'prostate gland', 55, 'prostate'), ('UBERON_0000310', 'breast', 65, 'breast'), ('UBERON_0001637', 'artery', 140, 'arterial')]
S15-PMC4466139	PMC4466139	6/2015	S15-PMC4466139	['moreover, in RECENT YEARS, Vitamin D deficiency HAS BEEN CONSIDERED AS a POSSIBLE cause of several diseases, including Microbial infections, Cardiovascular and allergic diseases, cancers, type 1 diabetes, multiple sclerosis and other Autoimmune diseases [1–10].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 73)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'microbial'), ('UBERON_0004535', 'cardiovascular system', 141, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 234, 'autoimmune')]
S29-PMC4488777	PMC4488777	5/2015	S29-PMC4488777	['lower Vitamin D levels HAVE BEEN FOUND in many Autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, type 1 diabetes mellitus, multiple sclerosis, Inflammatory Bowel diseases, Autoimmune Thyroid diseases [6,7].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 33)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 47, 'autoimmune'), ('UBERON_0001782', 'pigmented layer of retina', 194, 'inflammatory bowel'), ('UBERON_0001442', 'skeleton of manus', 223, 'autoimmune'), ('UBERON_0002046', 'thyroid gland', 234, 'thyroid')]
S95-PMC4624803	PMC4624803	10/2015	S95-PMC4624803	['Human studies have INDICATED that Vitamin D deficiency is ASSOCIATED with an INCREASED RISK of developing many diseases and disorders, like parkinson’s disease, epilepsy, depression, multiple sclerosis, schizophrenia, autism, and Autoimmune diseases like rheumatoid arthritis and type i diabetes mellitus [18–20].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 77)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 230, 'autoimmune')]
S117-PMC4684854	PMC4684854	12/2015	S117-PMC4684854	['finally, Gestational Vitamin D levels MAY IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the development of Adult onset multiple sclerosis [94].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('GO_0007565', 'female pregnancy', 9, 'gestational'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0007023', 'adult organism', 49, 'adult'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('UBERON_0007023', 'adult organism', 178, 'adult')]
S17-PMC4764019	PMC4764019	1/2016	S17-PMC4764019	['autoimmune disorders\ntwo SERIOUS Autoimmune diseases HAVE BEEN LINKED to low Vitamin D status in early Life, type 1 diabetes mellitus (dm1) and multiple sclerosis (ms).']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0001442', 'skeleton of manus', 33, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0000104', 'life cycle', 103, 'life')]
S98-PMC4903143	PMC4903143	5/2016	S98-PMC4903143	['in addition, Gestational Vitamin D levels MAY EVEN IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the Development Of Adult-onset multiple Sclerosis [33].']	[('INCOMPLETE_EVIDENCE', 42), ('ANOMALY_CURIOUS_FINDING', 46), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adult'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'pregnancy'), ('GO_0048513', 'animal organ development', 172, 'development of ... sclerosis'), ('UBERON_0007023', 'adult organism', 187, 'adult')]
S22-PMC4908484	PMC4908484	6/2016	S22-PMC4908484	"[""early Vitamin D deficiency MAY BE a RISK FACTOR for a number of disorders including schizophrenia, autism (thompson et\xa0al.1998; pilz et\xa0al.2011; chowdhury et\xa0al.2012), multiple sclerosis, parkinson's disease, and stroke (sun et\xa0al.2012).""]"	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
S8-PMC5129897	PMC5129897	10/2016	S8-PMC5129897	['introduction\nduring the past 15\xa0years, CONSIDERABLE INTEREST in the health BENEFITS of Vitamin D has emerged BECAUSE People with higher ultraviolet-b (uvb) exposure and/or 25-Hydroxyvitamin D [25(Oh)D] concentrations have lower RISK of many diseases and conditions.1our analysis is LIMITED to the diseases with the greatest economic EFFECT and the STRONGEST evidence of PROTECTIVE ROLES of Vitamin D—namely, cancer, Cardiovascular disease (cvd), dementia, diabetes mellitus (dm), falls and fractures, multiple sclerosis (ms), and Respiratory Tract infections.']	[('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 75), ('PROBABLE_UNDERSTANDING', 109), ('IMPORTANT_CONSIDERATION', 228), ('INCOMPLETE_EVIDENCE', 282), ('SUPERFICIAL_RELATIONSHIP', 333), ('INCOMPLETE_EVIDENCE', 348), ('SUPERFICIAL_RELATIONSHIP', 370), ('SUPERFICIAL_RELATIONSHIP', 381)]	11	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'people'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 172, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 416, 'cardiovascular'), ('UBERON_0000065', 'respiratory tract', 530, 'respiratory tract')]
S22-PMC5129897	PMC5129897	10/2016	S22-PMC5129897	['diseases included in THIS STUDY along with a brief overview of the mechanisms of Vitamin D for each disease and a listing of a few observational studies and clinical trials in support.diseasemechanismsobservational studiesclinical trialscancereffects on cells, Angiogenesis, and metastasis10breast and Colorectal cancer incidence11; survival12breast and all-cancer incidence13cvdeffects on Serum Cholesterol levels, Arterial stiffness, Insulin resistance, hyperglycemia, and increased incident Metabolic syndrome are POTENTIALLY PLAUSIBLE mediators8refs.14,15effect on cvd risk factors16dementiaregulation of Calcium Homeostasis, clearance of Amyloid-Β peptide, antioxidant and anti-inflammatory EFFECTS, and POSSIBLE protection against the neurodegenerative mechanisms ASSOCIATED with ad17incidence18\xa0dmimproves Insulin sensitivity and secretion, mainly via its anti-inflammatory properties19incidence20; meta-analysis21\xa0falls and fracturesreduces bone mass loss by reducing inflammation22; maintains cognition23; helps maintain muscle mass24ref.25ref.26mseffects on Regulatory T and B Cells27Ref.28\xa0respiratory infectionsinduction of Cathelicidin and defensins29; strengthens Adaptive and innate Immune System30Pneumonia31Influenza32,33; ari34\nad, alzheimer disease; ari, acute Respiratory Tract infection; cvd, Cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 517), ('INCOMPLETE_EVIDENCE', 529), ('SUPERFICIAL_RELATIONSHIP', 696), ('INCOMPLETE_EVIDENCE', 709), ('SUPERFICIAL_RELATIONSHIP', 770)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0001525', 'angiogenesis', 261, 'angiogenesis'), ('UBERON_0012652', 'colorectum', 302, 'colorectal'), ('UBERON_0001977', 'blood serum', 390, 'serum'), ('CHEBI_16113', 'cholesterol', 396, 'cholesterol'), ('UBERON_0001637', 'artery', 416, 'arterial'), ('PR_000045358', 'insulin family protein', 436, 'insulin'), ('GO_0008152', 'metabolic process', 494, 'metabolic'), ('GO_0055073', 'cadmium ion homeostasis', 609, 'calcium homeostasis'), ('PR_000004519', 'autism susceptibility gene 2 protein', 643, 'amyloid-β'), ('PR_000045358', 'insulin family protein', 813, 'insulin'), ('CL_0000815', 'regulatory T cell', 1068, 'regulatory T ...'), ('GO_0065007', 'biological regulation', 1068, 'regulatory'), ('CL_0000960', 'T3 B cell', 1085, 'B cells27Ref'), ('PR_000006009', 'alpha-catulin', 1136, 'cathelicidin'), ('GO_0051886', 'negative regulation of timing of anagen', 1178, 'adaptive ...'), ('UBERON_0003822', 'forelimb stylopod', 1198, 'immune system30Pneumonia31Influenza32'), ('UBERON_0000065', 'respiratory tract', 1280, 'respiratory tract'), ('UBERON_0004535', 'cardiovascular system', 1314, 'cardiovascular')]
S150-PMC5129897	PMC5129897	10/2016	S150-PMC5129897	['estimate of reduction in economic BURDEN in canada if all inhabitants had 25(Oh)D concentrations >100\xa0nmol/l after several years.outcometotal economic burden in 2016 ($b)reduction due to improving Vitamin D status (%)reduction in economic BURDEN due to improving Vitamin D status ($b)deaths in canada in 201139reduction in deaths, using deaths for 2011cancer7.3151.172,47610,870cvd24.6143.460,9108530dementia16.271.110,000700dm15.7182.871941290ms3.7401.5500 ref.92200osteoporosis (Hip fractures)5.0221.1\xa0\xa0respiratory infections6.1251.557671440total78.615.912.5156,84723,030\nnote: total deaths in canada in 2011 were 242,07488\n$b, billions of dollars; cvd, cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 239)]	2	[('CHEBI_71657', 'versiconol acetate', 74, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 74, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 263, 'vitamin D'), ('UBERON_0001464', 'hip', 481, 'hip')]
S39-PMC5310660	PMC5310660	1/2017	S39-PMC5310660	['this latter plays a significant ROLE, SINCE increased Serum Vitamin D concentration is ASSOCIATED with a decreased risk of multiple sclerosis [10,11], and Vitamin D supplementation during the first year of Life is ASSOCIATED with a significantly decreased risk of type 1 diabetes [12].']	[('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('UBERON_0000104', 'life cycle', 206, 'life')]
S80-PMC5706533	PMC5706533	11/2017	S80-PMC5706533	['figures are number (percentage) unless stated otherwisecharacteristicall trialsregular dose trials*Bolus dose trials*trials4337†8†intervention arms55469participants enrolled:\u2003total840676871031\u2003median within individual trials (min-max)133 (16-1134)133 (16-1134)118 (50-235)meta-analyses to which each trial contributed:\u2003median maternal outcomes (min-max)2 (0-6)2 (0-6)2 (0-4)\u2003median newborn/infant outcomes (min-max)3 (0-17)3 (0-17)4 (0-7)\u2003trials that DID not contribute data to any meta-analyses2 (4.7)2 (5.4)0 (0.0)geographical region:\u2003europe7 (16.3)7 (18.9)2 (25.0)\u2003south east asia6 (14.0)2 (5.4)4 (50.0)\u2003americas5 (11.6)5 (13.5)0 (0.0)\u2003eastern mediterranean21 (48.8)19 (51.4)2 (25.0)\u2003western pacific4 (9.3)4 (10.8)0 (0.0)health status at enrolment:\u2003generally healthy37 (86.0)33 (89.2)6 (75.0)\u2003Gestational diabetes4 (9.3)2 (5.4)2 (25.0)\u2003hypocalcaemia1 (2.3)1 (2.7)\u2003multiple sclerosis1 (2.3)1 (2.7)0 (0.0)baseline Vitamin D status‡:\u2003mean 25(Oh)D <30 nmol/l10 (23.3)9 (24.3)2 (25.0)\u2003mean 25(Oh)D ≥30 nmol/l23 (53.5)20 (54.1)3 (37.5)\u2003not reported10 (23.3)8 (21.6)3 (37.5)type of Vitamin D§:\u2003d24 (7.3)3 (6.5)1 (11.1)\u2003d348 (87.3)40 (87.0)8 (88.9)\u2003not reported3 (5.5)3 (6.5)0 (0.0)supplementation frequency§:\u2003daily31 (56.4)31 (67.4)—\u2003weekly5 (9.1)5 (10.9)—\u2003every 2 weeks6 (10.9)6 (13.0)—\u2003monthly3 (5.5)3 (6.5)—\u2003 every 2 months1 (1.8)1 (2.2)—\u2003single dose3 (5.5)—3 (33.3)\u2003two doses4 (7.3)—4 (44.4)\u2003other2 (3.6)—2 (22.2)intervention dose§¶:\u2003median (min-max)2000 (200-7543)2000 (200-7543)—\u2003regular dose <2000 iu/day24 (52.2)24 (52.2)—\u2003regular dose ≥2000 iu/day22 (47.8)22 (47.8)—control intervention type:\u2003placebo29 (67.4)23 (62.2)8 (100.0)\u2003active14 (32.6)14 (37.8)0 (0.0)median Vitamin D dose in active control arms (min-max)400 (200-600)400 (200-600)—timing of initiation of supplementation§:\u20031st trimester19 (34.5)18 (39.1)1 (11.1)\u20032nd trimester30 (54.5)24 (52.2)6 (66.7)\u20033rd trimester5 (9.1)3 (6.5)2 (22.2)\u2003not reported1 (1.8)1 (2.2)0 (0.0)\n*regular dosing refers to regimens in which Supplement was administered at least three times at regular frequency throughout Pregnancy (daily, weekly, every 2 weeks, monthly, or every 2 months ); bolus dosing refers to interventions administered either once or twice during intervention period.']	[('ANOMALY_CURIOUS_FINDING', 451)]	1	[('NCBITaxon_10088', 'Mus <genus>', 99, 'Bolus'), ('GO_0007565', 'female pregnancy', 796, 'Gestational'), ('CHEBI_27300', 'vitamin D', 915, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 939, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 988, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1078, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1671, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 1981, 'supplement'), ('GO_0007565', 'female pregnancy', 2062, 'pregnancy')]
S205-PMC5941617	PMC5941617	5/2018	S205-PMC5941617	['tuberculosis)xxxxamenorrheaxcancer (DIFFERENT types)xfxxxhepatitis cgxxrecurrent acute Lower Respiratory Tract infectionsgxxatopic dermatitisgxxatopic asthmagxxautoimmune diseaseshxxixcardiovascular diseases (especially hypertension)xxmetabolic syndrome, type 2 diabetesx\npes pediatric endocrine society, Es endocrine society, fcn federal commission for nutrition (switzerland), sahm society for adolescent health and medicine, aap american academy of pediatrics, eap european academy of pediatrics\nasuggested to guide Vitamin D prescription in Individuals with underlying RISKS requiring continuing supplementation all year long, if NECESSARY\nbgenetic conditions (Osteogenesis imperfecta, idiopathic juvenile osteoporosis, turner syndrome), Endocrine conditions (cushing syndrome, hypogonadism, hyperthyroidism, hyperparathyroidism, growth hormone deficiency, diabetes mellitus) ASSOCIATED with reduced bone mass\ncliving at higher latitudes in the winter and spring months\ndafrican-american and hispanic children\neobese children with additional RISK factors/symptoms for Vitamin D deficiency\nfsome lymphomas\ngpatients admitted to hospital\nhmultiple sclerosis, psoriasis, rheumatoid arthritis, dermatomyositis, systemic lupus erythematosus\nisystemic lupus erythematosus, juvenile idiopathic arthritis, juvenile dermatomyositis as associated with reduced bone mass\n\nSkeletal actions of Vitamin D\n\nnutritional rickets\nrickets is characterized by defective Mineralization Of developing Bone Tissue and reduced or absent Endochondral Ossification of the growth plate, with subsequent deformation [183,184].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('IMPORTANT_CONSIDERATION', 573), ('IMPORTANT_CONSIDERATION', 634), ('SUPERFICIAL_RELATIONSHIP', 880), ('SUPERFICIAL_RELATIONSHIP', 1046)]	5	[('UBERON_0004905', 'articulation', 87, 'lower respiratory tract'), ('CL_0002322', 'embryonic stem cell', 305, 'ES'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('NCBITaxon_1', 'root', 545, 'individuals'), ('GO_0001503', 'ossification', 665, 'osteogenesis'), ('GO_0006397', 'mRNA processing', 742, 'endocrine'), ('CHEBI_27300', 'vitamin D', 1072, 'vitamin D'), ('UBERON_0004288', 'skeleton', 1365, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 1385, 'vitamin D'), ('GO_0051217', 'molybdenum incorporation via L-aspartyl molybdenum bis(molybdopterin guanine dinucleotide)', 1454, 'mineralization of ...'), ('UBERON_0002481', 'bone tissue', 1483, 'bone tissue'), ('GO_0042695', 'thelarche', 1488, 'tissue'), ('GO_0001958', 'endochondral ossification', 1517, 'endochondral ossification'), ('UBERON_0010363', 'endochondral element', 1517, 'endochondral')]
S15-PMC5956785	PMC5956785	5/2018	S15-PMC5956785	['AS an Immune and inflammatory Mediator, Vitamin D is IMPLICATED in the pathogenesis of Autoimmune diseases including, as examples, multiple sclerosis, type 1 diabetes, rheumatoid arthritis, crohn’s disease, and chronic childhood arthritis [4–6].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('UBERON_0002405', 'immune system', 6, 'immune'), ('CHEBI_35222', 'inhibitor', 30, 'mediator'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 87, 'autoimmune')]
S239-PMC5956785	PMC5956785	5/2018	S239-PMC5956785	['exploring elements of Vitamin D status that MAY have a ROLE in disease development such as early Life and Gestational Vitamin D status as well as Genes in the Vitamin D pathway will help TO CLARIFY the ROLE of Vitamin D.\nseason of Birth HAS BEEN SUGGESTED to have an IMPACT on the risk of developing a number of Autoimmune diseases such as multiple sclerosis, type 1 diabetes and celiac disease [78].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 55), ('FUTURE_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 231, 'birth'), ('UBERON_0001442', 'skeleton of manus', 312, 'autoimmune')]
